Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua P Fessel

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Pulmonary Circulation|January 17, 2017
Shared gene expression patterns in mesenchymal progenitors derived from lung and epidermis in pulmonary arterial hypertension: identifying key pathways in pulmonary vascular diseaseChrista Gaskill, Shennea Marriott, Sidd Pratap, et al.
Circulation|March 24, 2016
Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial HypertensionEvan L Brittain, Megha Talati, Joshua P Fessel, et al.
Pulmonary Circulation|December 24, 2015
Expression of mutant bone morphogenetic protein receptor II worsens pulmonary hypertension secondary to pulmonary fibrosisAndrew J Bryant, Linda J Robinson, Christy S Moore, et al.
Circulation|October 22, 2015
Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular MetabolismXinping Chen, Megha Talati, Joshua P Fessel, et al.
Pulmonary Circulation|July 7, 2017
Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertensionRobert A Egnatchik, Evan L Brittain, Amy T Shah, et al.
The European Respiratory Journal|June 16, 2018
A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertensionAnna R Hemnes, Anandharajan Rathinasabapathy, Eric A Austin, et al.
Communications Biology|December 13, 2022
Neutrophil trafficking to the site of infection requires Cpt1a-dependent fatty acid β-oxidationLy Pham, Padmini Komalavilas, Alex M Eddie, et al.
American Journal of Physiology. Cell Physiology|May 30, 2014
Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertensionJames D West, Eric D Austin, Christa Gaskill, et al.
JCI Insight|January 11, 2019
Human PAH is characterized by a pattern of lipid-related insulin resistanceAnna R Hemnes, J Matthew Luther, Christopher J Rhodes, et al.
Pharmacogenetics and Genomics|May 26, 2017
Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adultsQuinn S Wells, Olivia J Veatch, Joshua P Fessel, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Pulmonary Circulation|January 17, 2017
Shared gene expression patterns in mesenchymal progenitors derived from lung and epidermis in pulmonary arterial hypertension: identifying key pathways in pulmonary vascular diseaseChrista Gaskill, Shennea Marriott, Sidd Pratap, et al.
Circulation|March 24, 2016
Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial HypertensionEvan L Brittain, Megha Talati, Joshua P Fessel, et al.
Pulmonary Circulation|December 24, 2015
Expression of mutant bone morphogenetic protein receptor II worsens pulmonary hypertension secondary to pulmonary fibrosisAndrew J Bryant, Linda J Robinson, Christy S Moore, et al.
Circulation|October 22, 2015
Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular MetabolismXinping Chen, Megha Talati, Joshua P Fessel, et al.
Pulmonary Circulation|July 7, 2017
Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertensionRobert A Egnatchik, Evan L Brittain, Amy T Shah, et al.
The European Respiratory Journal|June 16, 2018
A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertensionAnna R Hemnes, Anandharajan Rathinasabapathy, Eric A Austin, et al.
Communications Biology|December 13, 2022
Neutrophil trafficking to the site of infection requires Cpt1a-dependent fatty acid β-oxidationLy Pham, Padmini Komalavilas, Alex M Eddie, et al.
American Journal of Physiology. Cell Physiology|May 30, 2014
Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertensionJames D West, Eric D Austin, Christa Gaskill, et al.
JCI Insight|January 11, 2019
Human PAH is characterized by a pattern of lipid-related insulin resistanceAnna R Hemnes, J Matthew Luther, Christopher J Rhodes, et al.
Pharmacogenetics and Genomics|May 26, 2017
Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adultsQuinn S Wells, Olivia J Veatch, Joshua P Fessel, et al.
Pageof 7